erasmus university rotterdam arm orlando 03jun07 1 annual research meeting (arm) academyhealth,...

12
Erasmus University Rotterdam ARM Orlando 03Jun07 1 Annual Research Meeting (ARM) AcademyHealth, Orlando, 03Jun07 Evaluation of the Dutch Risk Equalization system: are the insurers confronted with predictable losses for the chronically ill? Wynand P.M.M. van de Ven ([email protected]) Pieter J.A. Stam Rene C.J.A. Van Vliet Erasmus University Rotterdam

Upload: imogen-little

Post on 21-Jan-2016

217 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Erasmus University Rotterdam ARM Orlando 03Jun07 1 Annual Research Meeting (ARM) AcademyHealth, Orlando, 03Jun07 Evaluation of the Dutch Risk Equalization

E

rasm

us

Un

iver

sity

Rot

terd

am

ARM Orlando 03Jun07 1

Annual Research Meeting (ARM)

AcademyHealth, Orlando, 03Jun07

Evaluation of the Dutch Risk Equalization system: are the insurers

confronted with predictable losses for the chronically ill?

  Wynand P.M.M. van de Ven ([email protected])

Pieter J.A. StamRene C.J.A. Van Vliet

Erasmus University Rotterdam

Page 2: Erasmus University Rotterdam ARM Orlando 03Jun07 1 Annual Research Meeting (ARM) AcademyHealth, Orlando, 03Jun07 Evaluation of the Dutch Risk Equalization

E

rasm

us

Un

iver

sity

Rot

terd

am

ARM Orlando 03Jun07 2

Health Insurance Act: 01jan06

• Mandate for everyone in the Netherlands to buy private health insurance;

• Standard benefits package;

• Selective contracting allowed;

• Open enrolment per product per insurer;

• Community rating per product per insurer per province;

• Risk equalization.

Page 3: Erasmus University Rotterdam ARM Orlando 03Jun07 1 Annual Research Meeting (ARM) AcademyHealth, Orlando, 03Jun07 Evaluation of the Dutch Risk Equalization

E

rasm

us

Un

iver

sity

Rot

terd

am

ARM Orlando 03Jun07 3

Risk Equalization Fund (REF)

premium (18+)

REF-payment based on risk adjusters

REF

Insured Insurer

Income-related contribution

Gov’t contribution (18-)

50%

50%

Two thirds of all households receive an income-related care allowance (at most € 420 per person per year)

Page 4: Erasmus University Rotterdam ARM Orlando 03Jun07 1 Annual Research Meeting (ARM) AcademyHealth, Orlando, 03Jun07 Evaluation of the Dutch Risk Equalization

E

rasm

us

Un

iver

sity

Rot

terd

am

ARM Orlando 03Jun07 4

Risk adjusters in the Dutch REFYear New risk adjuster

1992 Age/gender1995 Region, yes/no employee, disability1997 Age/disability2002 Pharmacy-based Cost Groups (PCGs)

(13 PCGs and about 7% of population)2004 Diagnostic Cost Groups (DCGs) (about 2% of pop)

yes/no self-employed2007 Multiple PCGs allowed (co-morbidity);

New PCGs: mental health (3% pop.), cancer and growth hormons(20 PCGs and about 16% of population)

Page 5: Erasmus University Rotterdam ARM Orlando 03Jun07 1 Annual Research Meeting (ARM) AcademyHealth, Orlando, 03Jun07 Evaluation of the Dutch Risk Equalization

E

rasm

us

Un

iver

sity

Rot

terd

am

ARM Orlando 03Jun07 5

Effects of selection

• Disincentive for insurers to be responsive to the high-risk consumers and contract the best quality care for them;

• Disincentive for providers to acquire the best reputation for treating chronic diseases;

• Selection more profitable than efficiency;

• High premiums for high-risk patients;

• Instability in the insurance market.

Page 6: Erasmus University Rotterdam ARM Orlando 03Jun07 1 Annual Research Meeting (ARM) AcademyHealth, Orlando, 03Jun07 Evaluation of the Dutch Risk Equalization

E

rasm

us

Un

iver

sity

Rot

terd

am

ARM Orlando 03Jun07 6

Objective & Research questions

Objective: evaluate the risk equalization system.

Research questions:

1. Are there identifiable subgroups of consumers with predictable lossses?

2. If so: How large are these subgroups? And how large are the predictable losses?In particular we focus on subgroups of persons with a chronic condition or with above average utilization rates in previous years.

Page 7: Erasmus University Rotterdam ARM Orlando 03Jun07 1 Annual Research Meeting (ARM) AcademyHealth, Orlando, 03Jun07 Evaluation of the Dutch Risk Equalization

E

rasm

us

Un

iver

sity

Rot

terd

am

ARM Orlando 03Jun07 7

Method

• Data: all information in the files of a large insurer (Agis) over the period 1998 – 2004, combined with an individual health survey (held in 2001); some 30,000 observations.

• Method: the Dutch 2007 risk adjusters are applied to the 2004-data. By comparing the predicted 2004-expenditures (based on the 2007 risk adjusters) with their actual 2004-expenditures we calculated the average profits and losses for many subgroups.

Page 8: Erasmus University Rotterdam ARM Orlando 03Jun07 1 Annual Research Meeting (ARM) AcademyHealth, Orlando, 03Jun07 Evaluation of the Dutch Risk Equalization

E

rasm

us

Un

iver

sity

Rot

terd

am

ARM Orlando 03Jun07 8

Results (costs and losses in euro)

Subgroup 2001 SizeCosts 2004

Predictable losses 2004

Self-reported health status fair/poor 21.2% 3404 541

Worst score Physical functioning (SF-36)

10.0% 4469 1140

Worst score Social functioning (SF-36) 10.0% 3190 649

Restricted in mobility (OECD-score) 14.9% 3740 653

Stroke, brain haemorrhage/ infarction 2.6% 4341 943

Myocardial infarction 3.3% 4755 789

Other serious heart disease 2.3% 4654 926

Some type of (malignant) cancer 4.8% 3440 689

Page 9: Erasmus University Rotterdam ARM Orlando 03Jun07 1 Annual Research Meeting (ARM) AcademyHealth, Orlando, 03Jun07 Evaluation of the Dutch Risk Equalization

E

rasm

us

Un

iver

sity

Rot

terd

am

ARM Orlando 03Jun07 9

Results (costs and losses in euro)

Subgroup 2001 SizeCosts 2004

Predictable losses 2004

High bloodpressure 15.2% 2961 342

Astma, chronic bronchitis, emphysema 8.1% 3182 460 3-6 self-reported conditions 22.3% 2848 333

7 or more self-reported conditions 2.9% 4833 1461

 Prescribed drugs (self reported, 2 weeks)

48.2% 2597 220

Contact specialist (self reported, 1 year) 39.8% 2586 317

Hospitalization (self reported, 1 year) 7.5% 3611 1034

Home care (self reported, 1 year) 2.2% 4258 1152

Page 10: Erasmus University Rotterdam ARM Orlando 03Jun07 1 Annual Research Meeting (ARM) AcademyHealth, Orlando, 03Jun07 Evaluation of the Dutch Risk Equalization

E

rasm

us

Un

iver

sity

Rot

terd

am

ARM Orlando 03Jun07 10

Results (costs and losses in euro)

Subgroup 1997 - 2001 SizeCosts 2004

Predictable losses 2004

In top-25% highest costs, in 3 of 5 years 5.9% 2537 238

In top-25% highest costs, in 4 of 5 years 4.5% 3240 304In top-25% highest costs, in 5 of 5 years 8.2% 6131 1757

Hospitalization in 2 of the 5 years 4.7% 3613 728

Hospitalization in 3 of the 5 years 1.1% 6606 2030

Hospitalization in 4 of the 5 years 0.3% 11763 5933

Hospitalization in 5 of the 5 years 0.1% 14373 6453

Page 11: Erasmus University Rotterdam ARM Orlando 03Jun07 1 Annual Research Meeting (ARM) AcademyHealth, Orlando, 03Jun07 Evaluation of the Dutch Risk Equalization

E

rasm

us

Un

iver

sity

Rot

terd

am

ARM Orlando 03Jun07 11

Conclusions1. Many subgroups, from <1% to 30% of

population, with predictable losses in the order of hundreds to thousands euros per person per year.

2. Also predictable losses for subgroups of insured whose disease is included as a risk adjuster in the risk equalization formula (e.g. heart problems, cancer, …).

3. Improvement of the risk equalization system needs a high priority. Otherwise the disadvantages due to risk selection may outweigh the advantages of competition.

Page 12: Erasmus University Rotterdam ARM Orlando 03Jun07 1 Annual Research Meeting (ARM) AcademyHealth, Orlando, 03Jun07 Evaluation of the Dutch Risk Equalization

E

rasm

us

Un

iver

sity

Rot

terd

am

ARM Orlando 03Jun07 12

New (potential) risk-adjusters

• Diagnostic information not only from prior hospitalization, but from all prior medical encounters (Diagnosis Treatment Combinations, DTCs) expected to be implemented in 2009;

• Multiyear-DCG’s;• A better indicator of invalidity (or

functional heath status);• Yes/no voluntary deductible;• ……